The burden of cerebrovascular disease can be reduced by providing optimal acute care in stroke units,1 including time-dependent reperfusion therapy. Intravenous thrombolytic therapy within the time window of 4.5 hours after stroke offers beneficial effect in selected pa- tients with acute ischemic stroke.2 Admission to hospital within this narrow time window presupposes the pa- tients’ recognition of stroke symptoms and knowledge of the necessity of rapid hospitalization. However, the lack of stroke awareness often results in delayed admis- sion, making thrombolysis accessible only for a small pro- portion of patients.3 Furthermore, knowledge of risk factors of cerebrovascular disease in the population is essential to improve risk profiles and thus prevent stroke.